Aristotle Capital Boston
Aristotle Capital Boston reported 118 stocks worth $1.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are HURN (2.6%), AER (2.2%) and HAE (2.2%). Compared with Q2 2026, the fund opened new positions in USPH, BSY and WFRD, added to NSIT, IJR and FLS, trimmed HURN, AER and HAE and sold out of EEFT, OII and KN.
Latest filing: what Aristotle Capital Boston did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() HURN Huron Consulting Group Inc | $29.9M | 2.6% | 190K | −27K (−12%) | 8 of 8 | |
| 2 | ![]() AER Aercap Holdings NV | $25M | 2.2% | 174K | −32K (−15%) | 8 of 8 | |
| 3 | ![]() HAE Haemonetics Corp Mass | $24.7M | 2.2% | 234K | −55K (−19%) | 8 of 8 | |
| 4 | ![]() HASI HA Sustainable Infra Cap Inc | $24.2M | 2.1% | 676K | −172K (−20%) | 8 of 8 | |
| 5 | ![]() HQY Healthequity Inc | $23.7M | 2.1% | 268K | −65K (−19%) | 8 of 8 | |
| 6 | ![]() MMSI Merit Med Sys Inc | $22M | 1.9% | 255K | −62K (−19%) | 8 of 8 | |
| 7 | ![]() ITRI Itron Inc | $19.2M | 1.7% | 222K | −46K (−17%) | 8 of 8 | |
| 8 | ![]() UMBF Umb Finl Corp | $19.1M | 1.7% | 147K | −34K (−19%) | 2 of 8 | |
| 9 | ![]() CRL Charles Riv Labs Intl Inc | $18.7M | 1.6% | 63K | −17K (−22%) | 8 of 8 | |
| 10 | ![]() CHE Chemed Corp New | $18M | 1.6% | 36K | −8,568 (−19%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() EEFT Euronet Worldwide Inc | $15M | 205K |
![]() OII Oceaneering Intl Inc | $9.9M | 245K |
![]() KN Knowles Corp | $8M | 192K |
![]() SLRC Slr Investment Corp C | $7.6M | 614K |
CROSS CTRY HEALTHCARE IN | $5.9M | 447K |
🔒 Free account: see all 7.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Aristotle Capital Boston 13F FAQ
What does Aristotle Capital Boston own?
Aristotle Capital Boston reported 118 stocks worth $1.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are HURN (2.6%), AER (2.2%) and HAE (2.2%). The table above lists every position in the filing (the top 10 without an account).
What did Aristotle Capital Boston buy and sell in Q3 2026?
Compared with Q2 2026: 6 new positions, 5 added to, 107 trimmed and 7 sold out. New positions include USPH, BSY and WFRD. It sold all of EEFT, OII and KN.
When will Aristotle Capital Boston file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Aristotle Capital Boston's portfolio worth?
The Q3 2026 filing reports $1.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.


























